ISTH SSC guidance (part 1) on developing new antithrombotic drugs for children: start paediatric formulation work early, use extrapolation and modelling to limit sample sizes, and make drugs proven safe and effective available where trials ran.
Guideline
Goldenberg et al. Development of new antithrombotic drugs for children (part 1): guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group